ARCHIMED
Lyon, France · Growth
Their stated focus (public profile)
ARCHIMED is a global private equity firm exclusively focused on healthcare industries, investing in profitable small- and mid-cap companies across seven healthcare sectors including Life Science Tools & Services, Biopharma Products, Diagnostics, MedTech, Healthcare IT, Consumer Health, and Animal & Environmental Health. The firm pursues growth buyout transactions, supporting portfolio companies through internationalization, innovation, M&A, and capacity expansion. With €9 billion in AUM, ARCHIMED invests between €10 million and €1 billion per company and maintains an impact/sustainability mandate with all funds classified under SFDR Article 8, 8+, or 9.
Stages: Growth
Sectors: Healthtech, Life sciences, Medtech
Check size: €10M to €1B
On file: 15 partners on record · 13 companies on record
Website: archimed.group
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.